Northeast Financial Consultants’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,068
Closed -$235K 338
2022
Q4
$235K Buy
+2,068
New +$235K 0.02% 274
2022
Q2
Sell
-2,102
Closed -$221K 398
2022
Q1
$221K Hold
2,102
0.01% 357
2021
Q4
$227K Hold
2,102
0.01% 322
2021
Q3
$230K Buy
+2,102
New +$230K 0.02% 317